DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants.
Epigenomics
; 15(6): 351-367, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-37249002
Full text:
1
Database:
MEDLINE
Main subject:
DNA Methylation
/
Neurodevelopmental Disorders
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article